RECURRENT PROSTATE CANCER
Clinical trials for RECURRENT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation combo aims to safely treat prostate cancer
Disease control OngoingThis early-phase study tests the safety of combining two types of radiation therapy for men with intermediate-risk prostate cancer. Participants receive a short internal radiation treatment followed by three weeks of highly targeted external radiation. The goal is to see if this …
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
New radiation approach aims to zap recurrent prostate cancer with fewer side effects
Disease control OngoingThis early-stage study tests a high-precision radiation technique called stereotactic body radiation therapy (SBRT) in 26 men whose prostate cancer has returned after surgery. The main goal is to find the safest and most effective dose by monitoring side effects. The approach tar…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
New hope for men with returning prostate cancer: 5-Day radiation blast
Disease control OngoingThis study tests a new approach for men whose prostate cancer comes back after surgery to remove the prostate. It combines a short course of hormone therapy (6 months) with highly focused radiation given in just 5 sessions. The goal is to see if this treatment can control the can…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Promising combo tackles tough prostate cancer
Disease control OngoingThis study tests a three-part treatment for men with intermediate or high-risk prostate cancer: a drug called enzalutamide, radiation therapy, and hormone therapy. The goal is to see how safe the combination is and how well it controls the cancer. About 25 men will take part, and…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Diet before chemo may cut side effects in cancer patients
Symptom relief OngoingThis study tests whether eating a low-calorie diet before chemotherapy can reduce side effects like fatigue, nausea, and mouth sores, and also improve how well the treatment works. About 130 adults with breast or prostate cancer will follow either a controlled low-calorie diet or…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC